Caroline Quat is named as a lobbyist on federal disclosure filings for 1 client through Astrazeneca Pharmaceuticals LP. The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Medicare/Medicaid, Pharmacy and Copyright/Patent/Trademark.
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Caroline Quat. See the Capitol Clarity rankings and method.